药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Solriamfetol
Canagliflozin may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromous sulfate
Canagliflozin may increase the excretion rate of Chromous sulfate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromium nicotinate
Canagliflozin may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromium gluconate
Canagliflozin may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromic nitrate
Canagliflozin may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Chromic citrate
Canagliflozin may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Potassium sulfate
Canagliflozin may increase the excretion rate of Potassium sulfate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Pentetic acid
Canagliflozin may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Patent Blue
Canagliflozin may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Bismuth subgallate
Canagliflozin may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Albutrepenonacog alfa
Canagliflozin may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Fenofibric acid
Canagliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Almasilate
Canagliflozin may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Ipecac
Canagliflozin may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Dichlorobenzyl alcohol
Canagliflozin may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Phosphocreatine
Canagliflozin may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Oxabolone cipionate
Canagliflozin may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Inositol
Canagliflozin may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Inosine pranobex
Canagliflozin may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Levosalbutamol
Canagliflozin may increase the excretion rate of Levosalbutamol which could result in a lower serum level and potentially a reduction in efficacy.